Jeff Cislini
Vermögen: 11 Mio $ am 31.08.2026
Vermögen: 11 Mio $ am 31.08.2026
Jeff Cislini is currently a Member at The State Bar of California and serves as Secretary, Senior Vice President & General Counsel at Revolution Medicines, Inc. since 2022.
Formerly, Mr. Cislini was an Associate at O'Melveny & Myers LLP and Vice President at Atara Biotherapeutics, Inc. Education includes undergraduate studies at Stanford University and graduate studies at Harvard Law School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.08.2026 | 55’907 ( 0.03% ) | 11 Mio $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| REVOLUTION MEDICINES, INC. | General Counsel | 01.09.2022 |
The State Bar of California
The State Bar of California Miscellaneous Commercial ServicesCommercial Services Operates as a official attorney licensing agency | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
O'Melveny & Myers LLP
O'Melveny & Myers LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
| ATARA BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
O'Melveny & Myers LLP
O'Melveny & Myers LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The State Bar of California
The State Bar of California Miscellaneous Commercial ServicesCommercial Services Operates as a official attorney licensing agency | Commercial Services |
Harvard Law School
Harvard Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Revolution Medicines, Inc.
Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen